AtriCure, Inc. (NASDAQ:ATRC)

CAPS Rating: 1 out of 5

The Company develops, manufactures and sells innovative surgical devices designed to create precise lesions, or scars, in cardiac and soft tissues.

Featured Broker Partners


Advertisement